Alchemia is a biopharmaceutical company with a balanced portfolio of assets;
- 1) an established revenue stream from Fondaparinux sodium sold by Dr Reddy's,
- 2) an oncology pipeline, and
- 3) a drug discovery platform used to access 3D chemical diversity.
ASX Share Price
Last:0.08 High: Low: Market Cap ($M):27